180 related articles for article (PubMed ID: 23159039)
1. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR
Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039
[TBL] [Abstract][Full Text] [Related]
2. Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.
Hens M; Vaidyanathan G; Welsh P; Zalutsky MR
Nucl Med Biol; 2009 Feb; 36(2):117-28. PubMed ID: 19217523
[TBL] [Abstract][Full Text] [Related]
3. Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
Hens M; Vaidyanathan G; Zhao XG; Bigner DD; Zalutsky MR
Nucl Med Biol; 2010 Oct; 37(7):741-50. PubMed ID: 20870149
[TBL] [Abstract][Full Text] [Related]
4. A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB).
Vaidyanathan G; Affleck DJ; Li J; Welsh P; Zalutsky MR
Bioconjug Chem; 2001; 12(3):428-38. PubMed ID: 11353542
[TBL] [Abstract][Full Text] [Related]
5. N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualization.
Choi J; Vaidyanathan G; Koumarianou E; McDougald D; Pruszynski M; Osada T; Lahoutte T; Lyerly HK; Zalutsky MR
Nucl Med Biol; 2014; 41(10):802-12. PubMed ID: 25156548
[TBL] [Abstract][Full Text] [Related]
6. N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At.
Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR
Nucl Med Biol; 2003 May; 30(4):351-9. PubMed ID: 12767391
[TBL] [Abstract][Full Text] [Related]
7. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.
Vaidyanathan G; Jestin E; Olafsen T; Wu AM; Zalutsky MR
Nucl Med Biol; 2009 Aug; 36(6):671-80. PubMed ID: 19647173
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
[TBL] [Abstract][Full Text] [Related]
10. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
11. Positively charged templates for labeling internalizing antibodies: comparison of N-succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR.
Foulon CF; Welsh PC; Bigner DD; Zalutsky MR
Nucl Med Biol; 2001 Oct; 28(7):769-77. PubMed ID: 11578897
[TBL] [Abstract][Full Text] [Related]
12. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
Foulon CF; Reist CJ; Bigner DD; Zalutsky MR
Cancer Res; 2000 Aug; 60(16):4453-60. PubMed ID: 10969792
[TBL] [Abstract][Full Text] [Related]
13. Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR
Nucl Med Biol; 2002 Jan; 29(1):1-11. PubMed ID: 11786270
[TBL] [Abstract][Full Text] [Related]
14. Observations on the Effects of Residualization and Dehalogenation on the Utility of
Chitneni SK; Koumarianou E; Vaidyanathan G; Zalutsky MR
Molecules; 2019 Oct; 24(21):. PubMed ID: 31671554
[TBL] [Abstract][Full Text] [Related]
15. A novel route to radioiodinated [123I]-N-succinimidyl-3-iodobenzoate, a reagent for radioiodination of bioactive peptides.
Al-Jammaz I; Al-Otaibi B; Amartey JK
Appl Radiat Isot; 2002 Nov; 57(5):743-7. PubMed ID: 12433050
[TBL] [Abstract][Full Text] [Related]
16. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Garg PK; Alston KL; Bigner DD; Zalutsky MR
Cancer Res; 1996 Nov; 56(21):4970-7. PubMed ID: 8895752
[TBL] [Abstract][Full Text] [Related]
17. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
[TBL] [Abstract][Full Text] [Related]
18. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate.
Reist CJ; Foulon CF; Alston K; Bigner DD; Zalutsky MR
Nucl Med Biol; 1999 May; 26(4):405-11. PubMed ID: 10382844
[TBL] [Abstract][Full Text] [Related]
19. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
[TBL] [Abstract][Full Text] [Related]
20. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
